The life sciences sector is at a crossroads as the FDA updates quality management standards. AI is now expected, and the FDA’s January 2025 draft guidance outlines its evaluation and implementation. Successful adoption depends on three key questions.
Safe and Sane: Understanding the FDA’s Risk-Based Approach to AI
Related Posts
Element Celebrates Opening of New Connected Technologies Laboratory in Surrey
Element Materials Technology (Element) hosted the grand opening of its new $10m Connected Technologies Center of Excellence in…
LK Metrology SURFACER Surface Roughness Probe
Coordinate measuring machine (CMM) manufacturer LK Metrology, whose manufacturing facility is in Derbyshire, UK, has announced the introduction…
Podcast | How to Use Validation Testing
A race inspired Dr. Rochelle Cook to share her insights on validation studies, also known as pilots. This…